Oct 4 (Reuters) - GSK (GSK.L), opens new tab, Sanofi (SASY.PA), opens new tab and CSL Ltd (CSL.AX), opens new tab have secured $72 million from the U.S. government to ramp up production of bird ...

CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the country’s supply of bird flu vaccines. The grant comes from the ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50. The company’s shares closed yesterday at p1,497. ...

Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £18.00. The company’s shares closed yesterday at p1,497. ...

As a nineties kid who grew up drinking bubble tea, I long ago wrote the drink off as a cheap indulgence, whose satisfying sugar rush quickly metabolizes into lingering regret. That changed last ...

Tea tree oil is promoted as a treatment for some skin conditions and for its antimicrobial properties. However, it is toxic when taken orally and may cause other unwanted side effects. Share on ...

We recently made a list of the 10 Best Global Stocks To Buy Now. In this piece, we will look at where GSK plc (NYSE:GSK) ranks among the top ten global stocks to buy. With the third quarter of ...

GlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The ...

That’s the humble origin story of Texas-based HTeaO, a specialty beverage concept that has surged in units and sales in recent years as its products delight the tea-drinking tastebuds of customers in ...

The world’s first RSV vaccines were approved by the FDA last year in the forms of GSK’s Arexvy and Pfizer’s Abrysvo. Both are designed to help prevent this common cold virus that can in the ...

GSK Plc CEO Emma Walmsley doesn’t want the company’s employees spending any time thinking about the ongoing litigation over its old heartburn drug Zantac, an issue that has weighed on the ...